WELCOME TO INVIDA

INVIDA is a Specialty Pharmaceutical Company focusing on commercialisation services [see PharmaLink] and its proprietary business [see Inovail].

INVIDA was set up as a Joint Venture by Temasek Holdings, Quintiles Transnational and the Zuellig Group in 2005. Commercialisation services have been provided in Asia Pacific for more than 50 years by preceding entities.

INNOVATION THROUGH UNDERSTANDING

Our understanding of the marketplace and managerial expertise provide us with insights to optimise today’s revenues and position innovation for tomorrow.

FROM INDIA TO JAPAN. FROM CHINA TO AUSTRALIA.

Our keen understanding, experience and expertise enable us to achieve our primary business objective: To deliver innovative solutions to the Asia Pacific marketplace.

Our broad access to the fastest growing region in the world gives us a competitive advantage in reaching a universe of 3 billion patients.

Inovail Holdings Pte Ltd is a newly-formed specialty pharmaceutical company focusing on market-driven innovation in the Asia Pacific Region.

Our areas of specialty are in primary care, dermatology and female healthcare. Within these areas, Inovail’s experienced teams are able to integrate capabilities ranging from market feasibility studies, regulatory affairs, marketing management, medical affairs. Our growth strategy is focused on driving innovation in the Asia Pacific Region.

Our activities range from in-licensing of innovative compounds to acquisition of existing brands. Inovail sees itself as a partner for the R&D based pharmaceutical industry that supports the refocusing of companies on their core businesses by assuming full responsibilities for various business areas, either by acquisition or in-licensing. Companies with investments in dermatology, complementary oncology and female healthcare will find value in our strategic partnership.

With the breadth of our services and the depth of our regional knowledge, we are the ideal strategic partner to bring your products to prominence in Asia Pacific.